Scientists engaged in precision medicine research focus intensely on target-based drug development. In doing so, they help improve the safety and efficacy profiles of future therapies by reducing ...

Nanoparticle-based drug delivery systems utilise the unique physicochemical properties of nanoscale carriers to enhance therapeutic efficacy whilst minimising systemic side effects. These formulations ...

DDS can be based on physical mechanisms like osmosis, diffusion, erosion, dissolution, and electro-transport or biochemical methods like monoclonal antibodies, gene therapy, vector systems, ...

Polyrizon Ltd., a biotechnology company focused on intranasal drug delivery systems, has reported promising preclinical results for its hydrogel-based Trap & Target (T&T) platform, developed in ...

With a $1 million Impact Award from the U.S. Department of Defense, Tianfu Wu, a University of Houston biomedical engineer, is developing a method to send medication directly to the spleen where ...

Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer ...

A couple of University of Nebraska professors have launched a startup company with the goal of bringing to market an innovative method for delivering drugs and other therapeutics to targeted locations ...

How do you send drugs to specific parts of the body so they do their job and avoid causing side effects elsewhere? According to researchers at Stanford University, the answer is a combination of ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed.

To improve chemotherapy dosing, engineers designed CLAUDIA, a way to continuously measure how much drug is in a patient's system during hours-long infusion. When cancer patients undergo chemotherapy, ...

Drug discovery has long relied on two key strategies: target-based and phenotypic screening. Recombinant technologies and genomics opened the door to modern target-based drug discovery (TBDD), ...